Abatacept Subq Injection 125MG/ML


Indications and Reactions:

Role Indications Reactions
Primary
Rheumatoid Arthritis 93.6%
Psoriatic Arthropathy 1.3%
Pain 0.9%
Depression 0.5%
Hypertension 0.5%
Juvenile Idiopathic Arthritis 0.4%
Systemic Lupus Erythematosus 0.4%
Ankylosing Spondylitis 0.2%
Anxiety 0.2%
Arthritis 0.2%
Cardiac Disorder 0.2%
Contraception 0.2%
Headache 0.2%
Inflammation 0.2%
Juvenile Arthritis 0.2%
Multiple Fractures 0.2%
Myalgia 0.2%
Osteoarthritis 0.2%
Rheumatoid Nodule 0.2%
Sjogren's Syndrome 0.2%
Drug Ineffective 23.1%
Drug Dose Omission 11.4%
Nasopharyngitis 6.9%
Pain 5.9%
Rheumatoid Arthritis 5.9%
Headache 4.5%
Pain In Extremity 4.5%
Nausea 3.7%
Surgery 3.7%
Rash 3.2%
Incorrect Storage Of Drug 2.9%
Pyrexia 2.9%
Urinary Tract Infection 2.9%
Vomiting 2.9%
Weight Decreased 2.9%
Injection Site Swelling 2.7%
Malaise 2.7%
Weight Increased 2.7%
Sinusitis 2.4%
Adverse Event 2.1%
Secondary
Rheumatoid Arthritis 86.1%
Ankylosing Spondylitis 2.8%
Osteoarthritis 2.8%
Pain 2.8%
Sjogren's Syndrome 2.8%
Systemic Lupus Erythematosus 2.8%
Rheumatoid Arthritis 10.0%
Ear Infection 5.0%
Hypersensitivity 5.0%
Loss Of Consciousness 5.0%
Off Label Use 5.0%
Pain 5.0%
Pericardial Effusion 5.0%
Poor Venous Access 5.0%
Restlessness 5.0%
Rotator Cuff Syndrome 5.0%
Skin Disorder 5.0%
Skin Exfoliation 5.0%
Swollen Tongue 5.0%
Systemic Lupus Erythematosus 5.0%
Systemic Lupus Erythematosus Rash 5.0%
Transient Ischaemic Attack 5.0%
Upper Respiratory Tract Congestion 5.0%
Weight Increased 5.0%
Wheezing 5.0%

Drug Data